National Healthcare Quality and Disparities Report
Latest available findings on quality of and access to health care
Data
- Data Infographics
- Data Visualizations
- Data Tools
- Data Innovations
- All-Payer Claims Database
- Healthcare Cost and Utilization Project (HCUP)
- Medical Expenditure Panel Survey (MEPS)
- AHRQ Quality Indicator Tools for Data Analytics
- State Snapshots
- United States Health Information Knowledgebase (USHIK)
- Data Sources Available from AHRQ
Search All Research Studies
AHRQ Research Studies Date
Topics
- Cardiovascular Conditions (1)
- Care Management (1)
- (-) Chronic Conditions (5)
- Emergency Department (1)
- (-) Healthcare Costs (5)
- Healthcare Delivery (1)
- Healthcare Utilization (2)
- Heart Disease and Health (1)
- Medical Expenditure Panel Survey (MEPS) (2)
- Medication (1)
- Primary Care (1)
- Respiratory Conditions (1)
- Shared Decision Making (1)
- Teams (1)
AHRQ Research Studies
Sign up: AHRQ Research Studies Email updates
Research Studies is a compilation of published research articles funded by AHRQ or authored by AHRQ researchers.
Results
1 to 5 of 5 Research Studies DisplayedBiener AI, Decker SL, Rohde F
AHRQ Author: Decker SL, Rohde F
Prevalence and treatment of chronic obstructive pulmonary disease (COPD) in the United States.
This infographic depicts MEPS data concerning the prevalence and treatment of chronic obstructive pulmonary disease, including information on costs, medications and other chronic conditions.
AHRQ-authored.
Citation: Biener AI, Decker SL, Rohde F .
Prevalence and treatment of chronic obstructive pulmonary disease (COPD) in the United States.
JAMA 2019 Aug 20;322(7):602. doi: 10.1001/jama.2019.10241..
Keywords: Medical Expenditure Panel Survey (MEPS), Respiratory Conditions, Care Management, Chronic Conditions, Healthcare Costs
Shaker M, Greenhawt M
A primer on cost-effectiveness in the allergy clinic.
This paper examines ways to incorporate cost-effectiveness into care at allergy clinics. The article discusses in general terms how to use cost-effective analyses (CEA) to grade health outcomes and economic benefits. The authors state that future research is needed to provide a better understanding of variation across population health state utilities for allergic conditions and to more accurately reflect quality adjusted life years for patients with allergies.
AHRQ-funded; HS024599.
Citation: Shaker M, Greenhawt M .
A primer on cost-effectiveness in the allergy clinic.
Ann Allergy Asthma Immunol 2019 Aug;123(2):120-28.e1. doi: 10.1016/j.anai.2019.05.012..
Keywords: Healthcare Costs, Chronic Conditions, Healthcare Delivery
Biener AI, Decker SL, Rohde F
AHRQ Author: Deck SL, Rohde F
Source of increased health care spending in the United States.
This infographic depicts MEPS information for five medical conditions that account for nearly 1/3 of all medical expenditures in 2015. Factors include the difference in spending associated with these conditions; the number of people treated for them; per capita costs; and related ambulatory visits and prescription drug costs as a proportion of health expenditures.
AHRQ-authored.
Citation: Biener AI, Decker SL, Rohde F .
Source of increased health care spending in the United States.
JAMA 2019 Mar 26;321(12):1147. doi: 10.1001/jama.2019.0679..
Keywords: Chronic Conditions, Healthcare Costs, Healthcare Utilization, Medical Expenditure Panel Survey (MEPS)
Smith GH, Shore S, Allen LA
Discussing out-of-pocket costs with patients: shared decision making for sacubitril-valsartan in heart failure.
This study examined how prescription costs can greatly impact decision-making in patients with serious medical conditions. Forty-nine patients with heart failure with reduced ejection fracture were recruited and interviewed about a drug sacrubitril-valsartan. The drug is considered effective but can be costly. Most patients (45/49) said they would take the medicine if the out-of-pocket cost was only $5 per month more than their current medication. But if the costs increased to $100 more per month then only 43% would switch to sacrubritil-valsartan. Only 20% of participants said their physician had discussed medication costs in the past year.
AHRQ-funded; HS026081.
Citation: Smith GH, Shore S, Allen LA .
Discussing out-of-pocket costs with patients: shared decision making for sacubitril-valsartan in heart failure.
J Am Heart Assoc 2019 Jan 8;8(1):e010635. doi: 10.1161/jaha.118.010635..
Keywords: Healthcare Costs, Shared Decision Making, Heart Disease and Health, Cardiovascular Conditions, Medication, Chronic Conditions
Meyers DJ, Chien AT, Nguyen KH
Association of team-based primary care with health care utilization and costs among chronically ill patients.
This study analyzed the value of team-based care practice on the treatment of patients, especially those with multiple chronic conditions. A large study was conducted using data from 18 academically affiliated primary care practices in the Boston, Massachusetts, area between 2011 and 2015. The study included 83,953 patients total with 19% of patients being younger than 18 years and the rest from 19-64 years of age. For patients with multiple chronic conditions, there was a statistically significant reduction in hospitalizations and emergency department visits. Among patients with less than 2 comorbidities, there was an increase in outpatient visits, hospitalizations and ambulatory care hospitalizations.
AHRQ-funded; HS000011.
Citation: Meyers DJ, Chien AT, Nguyen KH .
Association of team-based primary care with health care utilization and costs among chronically ill patients.
JAMA Intern Med 2019 Jan;179(1):54-61. doi: 10.1001/jamainternmed.2018.5118..
Keywords: Chronic Conditions, Emergency Department, Healthcare Costs, Healthcare Utilization, Primary Care, Teams